Minima Stent System Post- Approval Study (PAS)

Who May Qualify: - The subject's legally authorized representative has been informed of the nature of the device treatment, agrees to its provisions, and has provided written willing to sign a consent form - Indicated for treatment with the Minima Stent System per the IFU. Who Should NOT Join This Trial: - Active bloodstream infection requiring antibiotic therapy within 3 days prior to stent implantation - History of or active endocarditis (active treatment with antibiotics) within 180 days prior to stent implantation - Aortic or pulmonary artery aneurysm in the location targeted for treatment - Body weight \< 1.5 kg - Anatomic location of lesion judged by the investigator to not lend to the safe placement of a stent - Target vessels larger or smaller than the Minima System balloon size ranges - Known genetic syndrome known to be associated with vasculopathies such as but not limited to Williams syndrome, Loeys-Dietz syndrome, etc - Clinical scenario requiring that more than one vessel needs stent implantation at the time of the trial procedure. - Currently participating in an investigational drug study or another device study - Major or progressive non-cardiac disease resulting in a life expectancy of less than six months - Known hypersensitivity to aspirin or heparin and cannot be treated with other antiplatelet and/or antithrombotic medications - Known hypersensitivity to cobalt-chromium or contrast media that cannot be adequately premedicated Always talk to your doctor about whether this trial is right for you.